Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation
Publication Type:
Journal Article
Authors:
M R Charlton;
E J Gane;
Manns, M.P.;
R S Brown Jr.;
M P Curry;
P Y Kwo;
Robert J Fontana;
Gilroy, R.;
Teperman, L.;
Muir, A.J.;
J G McHutchison;
Symonds, W.T.;
Brainard, D.;
B J Kirby;
Dvory-Sobol, H.;
Denning, J.;
Arterburn, S.;
Samuel, D.;
Forns, X.;
N A TerraultSource:
Gastroenterology, Volume 148, Issue 1, p.108-117 (2015)
Keywords:
Anemia,
Biopsy,
Boston,
California,
Cities,
Creatinine,
Death,
Diarrhea,
Fatigue,
France,
Genotype,
genotype 1,
Germany,
HCV,
Headache,
hepatitis,
Hepatitis C,
hepatitis C virus,
Immunosuppressive Agents,
Infection,
interferon,
Israel,
Liver,
Liver Transplantation,
Male,
Massachusetts,
Medicine,
methods,
Michigan,
Minnesota,
New York,
New Zealand,
North Carolina,
Paris,
Patients,
resistance,
Ribavirin,
Safety,
San Francisco,
secondary,
sofosbuvir,
Spain,
sustained virologic response,
therapy,
transplantation,
treatment,
Universities
